Lambros Stamatakis MD

Author

Lambros Stamatakis, MD, Urology

Lambros Stamatakis, MD, is the director of Urologic Oncology at MedStar Washington Hospital Center, and specializes in malignant diseases of the urologic system.

View Doctor Profile

Using Blue Light Cystoscopy to Treat Bladder Cancer

by Lambros Stamatakis, MD, Urology
January 28, 2021

Did you know that bladder cancer is the fourth most common non-skin cancer in the U.S.? Unlike prostate cancer, for…

Kidney Cancer: What You Need To Know

by Lambros Stamatakis, MD, Urology
July 07, 2020

Kidney (renal) cancer is on the rise. In Washington, D.C. alone, 100 to 150 people a year are expected to…

Immunotherapy: The future course of bladder cancer care

by Lambros Stamatakis, MD, Urology
December 14, 2017

In the 1990s, the Food and Drug Administration (FDA) approved a treatment for bladder cancer called Bacillus Calmette-Guerin therapy, or…

Treating bladder cancer: What patients need to know

by Lambros Stamatakis, MD, Urology
November 14, 2017

While bladder cancer doesn’t get as much press as colon or lung cancer, it’s the fourth-most common type of cancer…

What to do when prostate cancer biopsy/PSA test results conflict

by Ross E. Krasnow, MD, Urologic Oncologist, Lambros Stamatakis, MD, Urology
September 28, 2017

Prostate cancer can be challenging to detect. Our screening and diagnostic tools—prostate-specific antigen (PSA) testing and transrectal ultrasound-guided (TRUS) prostate…

Can an advanced MRI improve prostate cancer screening?

by Keith Kowalczyk, MD, Urologist and Robotic Surgeon, Lambros Stamatakis, MD, Urology
January 27, 2017

Prostate cancer is notoriously tricky to detect. It often doesn’t cause symptoms until it’s advanced, and there are no routine…